Your team can monitor disease markers, adjust IBD medications if needed, and recommend pausing GLP-1 during flares to protect your gastrointestinal health while pursuing weight management or metabolic goals
2021: More than 10,000 semaglutide-related adverse events are reported to the FDA Adverse Reporting System (FAERS)
Talk to your surgeon or contact our office to review: Your insurance benefits Whether you have Lantern or Transcarent Self-pay pricing and financing options We believe every patient deserves access to the life-changing, affordable treatment that bariatric surgery provides.
As studies progress, these treatments may emerge as foundational components in a comprehensive approach to mitigating the impact of diabetic kidney disease, promoting both longevity and quality of life for those facing this complex illness
Research also suggests GLP-1 users are over two times more likely to experience GERD than those not taking the medication, and their risk of developing gallstones increases by nearly 50%